fda compounding semaglutide update Despite ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market FDA proposes a new GLP-1

Weight loss is of course beneficial, but it doesnt fully explain the benefits seen in the heart, kidneys and liver

Like any medication, individual response varies, and medical supervision provides the safest approach for extended use

In the initial stage of carcinogenesis, ROS play a variety of roles, including mediating the activation of carcinogens, causing DNA damage, and interfering with responses to DNA damage [37,38,39]

You already know the dangers of sun exposure and tanning beds (including skin cancer, premature aging and more)

Anything else is marketing until proven otherwise Higher doses can cause GI issues for some people